SAB Biotherapeutics
SABS
SABS
24 hedge funds and large institutions have $15.2M invested in SAB Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 21 reducing their positions, and 21 closing their positions.
Holders
24
Holders Change
-18
Holders Change %
-42.86%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
21
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$245K |
| 2 |
PGAM
2
Princeton Global Asset Management
Princeton,
New Jersey
|
$2.27K |
| 3 |
HI
3
Harbour Investments
Madison,
Wisconsin
|
$227 |
Top Sellers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$4.17M |
| 2 |
RI
2
RTW Investments
New York
|
$4.17M |
| 3 |
3
Marshall Wace
London,
United Kingdom
|
$2.08M |
| 4 |
SC
4
Sessa Capital
New York
|
$2.08M |
| 5 |
CC
5
Commodore Capital
New York
|
$832K |
